The roles of CD147 in the progression of gliomas

References

• Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997-1003
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10(5):459-66
   PubMed Web of Science ®Google Scholar
• Slotty PJ, Siantidis B, Beez T, et al. The impact of improved treatment strategies on overall survival in glioblastoma patients. Acta Neurochir (Wien) 2013;155(6):959-63
   PubMed Web of Science ®Google Scholar
• Iuchi T, Hatano K, Kodama T, et al. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 2014;88(4):793-800
   PubMed Web of Science ®Google Scholar
• Marko NF, Weil RJ, Schroeder JL, et al. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 2014;32(8):774-82
   PubMed Web of Science ®Google Scholar
• Tate MC, Aghi MK. Biology of angiogenesis and invasion in glioma. Neurotherapeutics 2009;6(3):447-57
   PubMed Web of Science ®Google Scholar
• Altruda F, Cervella P, Gaeta ML, et al. Cloning of cDNA for a novel mouse membrane glycoprotein (gp42): shared identity to histocompatibility antigens, immunoglobulins and neural-cell adhesion molecules. Gene 1989;85(2):445-51
   PubMed Web of Science ®Google Scholar
• Miyauchi T, Kanekura T, Yamaoka A, et al. Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the beta-chain of major histocompatibility complex class II antigen. J Biochem 1990;107(2):316-23
   PubMed Web of Science ®Google Scholar
• Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 1982;109(3):1026-34
   PubMed Web of Science ®Google Scholar
• Biswas C. Collagenase stimulation in cocultures of human fibroblasts and human tumor cells. Cancer Lett 1984;24(2):201-7
   PubMed Web of Science ®Google Scholar
• Biswas C, Zhang Y, DeCastro R, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995;55(2):434-9
   PubMed Web of Science ®Google Scholar
• Zhong WD, Liang YX, Lin SX, et al. Expression of CD147 is associated with prostate cancer progression. Int J Cancer 2012;130(2):300-8
   PubMed Web of Science ®Google Scholar
• Zhong X, Li M, Nie B, et al. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma. Ann Surg Oncol 2013;20(3):1044-52
   PubMed Web of Science ®Google Scholar
• Hibino T, Sakaguchi M, Miyamoto S, et al. S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis. Cancer Res 2013;73(1):172-83
   PubMed Web of Science ®Google Scholar
• Zhao S, Ma W, Zhang M, et al. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Med Oncol 2013;30(1):335
   PubMed Web of Science ®Google Scholar
• Zhu S, Chu D, Zhang Y, et al. EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer. Med Oncol 2013;30(1):369
   PubMed Web of Science ®Google Scholar
• Huang T, Chen MH, Wu MY, Wu XY. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2013;122(3):210-15
   PubMed Web of Science ®Google Scholar
• Wu J, Hao ZW, Zhao YX, et al. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma. J Transl Med 2014;12:190
   PubMed Web of Science ®Google Scholar
• Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002;99(4):520-5280
   PubMed Web of Science ®Google Scholar
• Chen X, Lin J, Kanekura T, et al. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 2006;66(23):11323-30
   PubMed Web of Science ®Google Scholar
• Kim Y, Choi JW, Lee JH, Kim YS. Expression of lactate/H(+) symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses. Hum Pathol 2015;46(1):104-12
   PubMed Web of Science ®Google Scholar
• Chu D, Zhu S, Li J, et al. CD147 expression in human gastric cancer is associated with tumor recurrence and prognosis. PLoS One 2014;9(6):e101027
   PubMed Web of Science ®Google Scholar
• Li H, Chen J, He M, et al. [Expression of CD147 and MMP-2 in human gliomas and its correlations with prognosis]. Sichuan Da Xue Xue Bao Yi Xue Ban 2007;38(3):396-9
   PubMedGoogle Scholar
• Gu J, Zhang C, Chen R, et al. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas. Eur J Pediatr 2009;168(6):705-10
   PubMed Web of Science ®Google Scholar
• Chu T, Chen X, Yu J, et al. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. Pathol Oncol Res 2011;17(3):705-11
   PubMed Web of Science ®Google Scholar
• Tian L, Zhang Y, Chen Y, et al. EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma. PLoS One 2013;8(3):e58069
   PubMed Web of Science ®Google Scholar
• Tsai WC, Chen Y, Huang LC, et al. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas. J Neurooncol 2013;114(3):281-90
   PubMed Web of Science ®Google Scholar
• Yang M, Yuan Y, Zhang H, et al. Prognostic significance of CD147 in patients with glioblastoma. J Neurooncol 2013;115(1):19-26
   PubMed Web of Science ®Google Scholar
• Kasinrerk W, Fiebiger E, Stefanova I, et al. Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule. J Immunol 1992;149(3):847-54
   PubMed Web of Science ®Google Scholar
• Schlosshauer B, Herzog KH. Neurothelin: an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons. J. Cell Biol 1990;110(4):1261-74
   PubMed Web of Science ®Google Scholar
• Fadool JM, Linser PJ. 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 1993;196(4):252-62
   PubMed Web of Science ®Google Scholar
• Seulberger H, Lottspeich F, Risau W. The inducible blood–brain barrier specific molecule HT7 is a novel immunoglobulin-like cell surface glycoprotein. EMBO J 1990;9(7):2151-8
   PubMed Web of Science ®Google Scholar
• Fossum S, Mallett S, Barclay AN. The MRC OX-47 antigen is a member of the immunoglobulin superfamily with an unusual transmembrane sequence. Eur J Immunol 1991;21(3):671-9
   PubMed Web of Science ®Google Scholar
• Nehme CL, Cesario MM, Myles DG, et al. Breaching the diffusion barrier that compartmentalizes the transmembrane glycoprotein CE9 to the posterior-tail plasma membrane domain of the rat spermatozoon. J Cell Biol 1993;120(3):687-94
   PubMed Web of Science ®Google Scholar
• Kanekura T, Miyauchi T, Tashiro M, Muramatsu T. Basigin, a new member of the immunoglobulin superfamily: genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct. Funct 1991;16(1):23-30
   PubMed Web of Science ®Google Scholar
• Muramatsu T, Miyauchi T. Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 2003;18(3):981-7
   PubMed Web of Science ®Google Scholar
• Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007;83(3):283-95
   PubMed Web of Science ®Google Scholar
• Bi J, Li Y, Sun F, et al. Basigin null mutant male mice are sterile and exhibit impaired interactions between germ cells and Sertoli cells. Dev Biol 2013;380(2):145-56
   PubMed Web of Science ®Google Scholar
• Philp NJ, Ochrietor JD, Rudoy C, et al. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci 2003;44(3):1305-11
   PubMed Web of Science ®Google Scholar
• Yurchenko V, O’Connor M, Dai WW, et al. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun 2001;288(4):786-8
   PubMed Web of Science ®Google Scholar
• Fadool JM, Linser PJ. 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 1993;196(4):252-62
   PubMed Web of Science ®Google Scholar
• Liang Q, Xiong H, Gao G, et al. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 2005;4(7):759-62
   PubMed Web of Science ®Google Scholar
• Miranda-Goncalves V, Honavar M, Pinheiro C, et al. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro Oncol 2013;15(2):172-88
   PubMed Web of Science ®Google Scholar
• Li Y, Wu J, Song F, et al. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin beta1 to modulate malignant properties of hepatoma cells. J Biol Chem 2012;287(7):4759-72
   PubMed Web of Science ®Google Scholar
• Nehme CL, Fayos BE, Bartles JR. Distribution of the integral plasma membrane glycoprotein CE9 (MRC OX-47) among rat tissues and its induction by diverse stimuli of metabolic activation. Biochem J 1995;310(Pt 2):693-8
   PubMed Web of Science ®Google Scholar
• Li R, Huang L, Guo H, Toole BP. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol 2001;186(3):371-9
   PubMed Web of Science ®Google Scholar
• Sluijter JP, Pulskens WP, Schoneveld AH, et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 2006;37(1):235-9
   PubMed Web of Science ®Google Scholar
• Beesley AH, Weller RE, Kees UR. The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse. Br J Haematol 2008;142(6):1000-2
   PubMed Web of Science ®Google Scholar
• Jia L, Zhou H, Wang S, et al. Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro. IUBMB Life 2006;58(4):209-16
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhao Y, Jiang L, et al. Glycomic alterations are associated with multidrug resistance in human leukemia. Int J Biochem Cell Biol 2012;44(8):1244-53
   PubMed Web of Science ®Google Scholar
• Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer 2006;119(8):1800-10
   PubMed Web of Science ®Google Scholar
• Li Y, Xu J, Chen L, et al. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology 2009;54(6):677-87
   PubMed Web of Science ®Google Scholar
• Han ZD, Bi XC, Qin WJ, et al. CD147 expression indicates unfavourable prognosis in prostate cancer. Pathol Oncol Res 2009;15(3):369-74
   PubMed Web of Science ®Google Scholar
• Han ZD, He HC, Bi XC, et al. Expression and clinical significance of CD147 in genitourinary carcinomas. J Surg Res 2010;160(2):260-7
   PubMed Web of Science ®Google Scholar
• Liu F, Cui L, Zhang Y, et al. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat 2010;124(3):677-88
   PubMed Web of Science ®Google Scholar
• Zhu S, Li Y, Mi L, et al. Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma. Dig Dis Sci 2011;56(12):3569-76
   PubMed Web of Science ®Google Scholar
• Ma L, Li GZ, Wu ZS, Meng G. Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression. Med Oncol 2014;31(1):773
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen S, Gou WF, et al. The role of EMMPRIN expression in ovarian epithelial carcinomas. Cell Cycle 2013;12(17):2899-913
   PubMed Web of Science ®Google Scholar
• Zheng HC, Wang W, Xu XY, et al. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level. J Cancer Res Clin Oncol 2011;137(4):585-96
   PubMed Web of Science ®Google Scholar
• Zheng HC, Takahashi H, Murai Y, et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 2006;95(10):1371-8
   PubMed Web of Science ®Google Scholar
• Fei F, Li X, Xu L, et al. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway. Ann Surg Oncol 2014;21(13):4359-68
   PubMed Web of Science ®Google Scholar
• Zhu B, Block NL, Lokeshwar BL. Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion. Ann N Y Acad Sci 1999;878:642-6
   PubMed Web of Science ®Google Scholar
• Guo H, Li R, Zucker S, Toole BP. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000;60(4):888-91
   PubMed Web of Science ®Google Scholar
• Zeng W, Su J, Wu L, et al. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation. Curr Mol Med 2014;14(1):163-73
   PubMed Web of Science ®Google Scholar
• Lafleur MA, Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 2003;5(23):1-39
   PubMedGoogle Scholar
• Chen Y, Zhang H, Gou X, et al. Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis. Cancer Lett 2009;278(1):113-21
   PubMed Web of Science ®Google Scholar
• Voigt H, Vetter-Kauczok CS, Schrama D, et al. CD147 impacts angiogenesis and metastasis formation. Cancer Invest 2009;27(3):329-33
   PubMed Web of Science ®Google Scholar
• Kuang YH, Chen X, Su J, et al. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. Cancer Lett 2009;276(2):189-95
   PubMed Web of Science ®Google Scholar
• Yang JM, Xu Z, Wu H, et al. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003;1(6):420-7
   PubMed Web of Science ®Google Scholar
• Afonso J, Santos LL, Miranda-Goncalves V, et al. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.LID. Mol Carcinog 2014
   PubMed Web of Science ®Google Scholar
• Toole BP, Slomiany MG. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat 2008;11(3):110-21
   PubMed Web of Science ®Google Scholar
• Maeda K, Kosugi T, Sato W, et al. CD147/Basigin Limits Lupus Nephritis and Th17 Cell Differentiation in Mice by Inhibiting the Interleukin-6/STAT-3 Pathway. Arthritis Rheumatol 2015;67(8):2185-95
   Web of Science ®Google Scholar
• Wang CH, Yao H, Chen LN, et al. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1alpha-mediated pathway in rheumatoid arthritis. Arthritis Rheum 2012;64(6):1818-27
   PubMed Web of Science ®Google Scholar
• Sameshima T, Nabeshima K, Toole BP, et al. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer 2000;88(1):21-7
   PubMed Web of Science ®Google Scholar
• Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39(2):235-50
   PubMed Web of Science ®Google Scholar
• Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001;61(5):2276-81
   PubMed Web of Science ®Google Scholar
• Koga K, Aoki M, Sameshima T, et al. Synthetic emmprin peptides inhibit tumor cell-fibroblast interaction-stimulated upregulation of MMP-2 and tumor cell invasion. Int J Oncol 2011;39(3):657-64
   PubMed Web of Science ®Google Scholar
• Sameshima T, Nabeshima K, Toole BP, et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000;157(2):177-84
   PubMed Web of Science ®Google Scholar
• Ru NY, Wu J, Chen ZN, Bian H. HAb18G/CD147 is involved in TGF-beta-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion. Cell Biol Int 2015;39(1):44-51
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285(21):1182-6
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF-A: a critical regulator of blood vessel growth. Eur Cytokine Netw 2009;20(4):158-63
   PubMed Web of Science ®Google Scholar
• Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362(6423):841-4
   PubMed Web of Science ®Google Scholar
• Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438(7070):967-74
   PubMed Web of Science ®Google Scholar
• Cloughesy T. FDA accelerated approval benefits glioblastoma. Lancet Oncol 2010;11(12):1120
   PubMed Web of Science ®Google Scholar
• Chinot OL, Wick W, Mason W, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 2014;370(8):709-22
   PubMed Web of Science ®Google Scholar
• Lucio-Eterovic AK, Piao Y, de Groot JF. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Clin Cancer Res 2009;15(14):4589-99
   PubMed Web of Science ®Google Scholar
• Chen Y, Gou X, Ke X, et al. Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I. PLoS ONE 2012;7(7):e40965
   PubMed Web of Science ®Google Scholar
• Kirk P, Wilson MC, Heddle C, et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000;19(15):3896-904
   PubMed Web of Science ®Google Scholar
• WARBURG O. On respiratory impairment in cancer cells. Science 1956;124(3215):269-70
   PubMed Web of Science ®Google Scholar
• Beckner ME, Stracke ML, Liotta LA, Schiffmann E. Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst 1990;82(23):1836-40
   PubMed Web of Science ®Google Scholar
• Oudard S, Arvelo F, Miccoli L, et al. High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 1996;74(6):839-45
   PubMed Web of Science ®Google Scholar
• Mineura K, Yasuda T, Kowada M, et al. Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 1986;8(3):164-8
   PubMedGoogle Scholar
• Hirata K, Terasaka S, Shiga T, et al. (1)(8)F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. Eur J Nucl Med Mol Imaging 2012;39(5):760-70
   PubMed Web of Science ®Google Scholar
• Fukumura D, Xu L, Chen Y, et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 2001;61(16):6020-4
   PubMed Web of Science ®Google Scholar
• Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9(6):425-34
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006;66(13):6699-707
   PubMed Web of Science ®Google Scholar
• Walters DK, Arendt BK, Jelinek DF. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells. Cell Cycle 2013;12(19):3175-83
   PubMed Web of Science ®Google Scholar
• Li S, Nguyen TT, Bonanno JA. CD147 required for corneal endothelial lactate transport. Invest Ophthalmol Vis Sci 2014;55(7):4673-81
   PubMedGoogle Scholar
• Gallagher SM, Castorino JJ, Wang D, Philp NJ. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 2007;67(9):4182-9
   PubMed Web of Science ®Google Scholar
• Su J, Chen X, Kanekura T. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 2009;273(1):140-7
   PubMed Web of Science ®Google Scholar
• Dean NR, Newman JR, Helman EE, et al. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res 2009;15(12):4058-65
   PubMed Web of Science ®Google Scholar
• Xu J, Shen ZY, Chen XG, et al. A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation. Hepatology 2007;45(2):269-76
   PubMed Web of Science ®Google Scholar
• Fan X, Wu W, Shi H, Han J. RNA interference targeting CD147 inhibits the invasion of human cervical squamous carcinoma cells by downregulating MMP-9. Cell Biol. Int 2013;37(7):737-41
   PubMed Web of Science ®Google Scholar
• Sangboonruang S, Thammasit P, Intasai N, et al. EMMPRIN reduction via scFv-M6-1B9 intrabody affects alpha3beta1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2. Cancer Gene Ther 2014;21(6):246-55
   PubMed Web of Science ®Google Scholar